These include semaglutide (Wegovy, Ozempic and Rybelsus), tirzepatide (Mounjaro), and liraglutide, which is sold under several brand names
clinical trials showed rates similar to placebo
It is the only way to catch nutrient deficiencies early, monitor metabolic markers, and ensure the medication is working safely
Moreover, the clinical significance of lean mass loss cannot be inferred solely from quantitative measures, as muscle quality, strength, and metabolic function may be preserved or even improved in some contexts [15,16,17]
Yes, osteoporosis medications such as bisphosphonates can be safely co-prescribed with GLP-1 receptor agonists